Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 16-Sep-24
Select bar for recommendation details.
Recommendations | 16-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 5 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Marinus Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 13.00 and a low estimate of 2.00. The median estimate represents a 496.03% increase from the last price of 1.51.
High | 760.9% | 13.00 |
Med | 496.0% | 9.00 |
Low | 32.5% | 2.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate | -0.36% |
Average growth rate | -75.36% |
More ▼
Revenue history & estimates in USD
Average growth rate | +7.59% |
Average growth rate | +293.62% |
More ▼